NCT Number: NCT00143325
An Open Label Study That Compares Varenicline to Transdermal Nicotine Patch for Smoking Cessation
Open-label comparison of standard 12-week regimen of varenicline with standard 10-week regimen of transdermal nicotine patch for smoking cessation.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–75 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 3
Primary location
Pfizer Investigational Site, Brussels, Belgium
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Subjects must have smoked an average of at least 15 cigarettes per day during the past year and over the month prior to the screening visit, with no period of abstinence greater than 3 months in the past year.
Exclusion criteria
- Subjects with clinically significant cardiovascular disease in the past 6 months.
Treatment and study plan
Primary outcomes
-
Continuous abstinence for the last 4 weeks of varenicline and NRT (Nicotine Replacement Therapy) treatment period
Secondary outcomes
-
Continuous abstinence last 4 weeks of treatment through Weeks 24 and 52
-
7-day point prevalence of abstinence: end of treatment, Weeks 24 and 52
-
4-week Point Prevalence of abstinence at Week 52
-
Long-Term Quit Rate at Weeks 24 and 52
-
Minnesota Nicotine Withdrawal Scale
-
Smoking Effects Inventory
Interested in participating?
Looking for future studies?
Notify MeSponsors and collaborators
Lead sponsor
Pfizer
Industry
Registry information
Official study title
An Open-Label, Multicenter Study With Follow-Up Evaluating the Safety and Efficacy of Varenicline Tartrate in Comparison to Transdermal Nicotine Patch for Smoking Cessation
Important dates
- Study start
- 2005
- Study completion
- 2006
- First posted
- Sep 2, 2005
- Registry last updated
- Jun 4, 2007
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Partnering With Food Bank to Provide Tobacco Treatment to Underserved Smokers
NCT05004662
Behavior, Health Behavior
Tampa, Florida, United States
View Trial DetailsEvaluation of a Smoking Cessation Program for Long-Term Abstinence
NCT06746025
Behavior, Behavior, Addictive
Naples, Florida, United States
View Trial DetailsWhatsApp Embedded in Routine Service Delivery for Smoking Cessation
NCT03714971
Behavior, Health Behavior
Izmir, Turkey (Türkiye)
View Trial DetailsCreation of an Infrastructure to Support Delivery of mHealth Interventions for Cancer Patients
NCT06909357
Behavior, Health Behavior
Coral Gables, Florida, United States
View Trial Details